History of comorbidities and survival of ovarian cancer patients, results from the ovarian cancer association consortium

Albina N. Minlikeeva, Jo L. Freudenheim, Kevin H. Eng, Rikki A. Cannioto, Grace Friel, J. Brian Szender, Brahm Segal, Kunle Odunsi, Paul Mayor, Brenda Diergaarde, Emese Zsiros, Linda E. Kelemen, Martin Kobel, Helen Steed, Anna Defazio, Susan J. Jordan, Peter A. Fasching, Matthias W. Beckmann, Harvey A. Risch, Mary Anne RossingJennifer A. Doherty, Jenny Chang-Claude, Marc T. Goodman, Thilo Dörk, Robert Edwards, Francesmary Modugno, Roberta B. Ness, Keitaro Matsuo, Mika Mizuno, Beth Y. Karlan, Ellen L. Goode, Susanne K. Kjaer, Estrid Høgdall, Joellen M. Schildkraut, Kathryn L. Terry, Daniel W. Cramer, Elisa V. Bandera, Lisa E. Paddock, Lambertus A. Kiemeney, Leon F.A.G. Massuger, Rebecca Sutphen, Hoda Anton-Culver, Argyrios Ziogas, Usha Menon, Simon A. Gayther, Susan J. Ramus, Aleksandra Gentry-Maharaj, Celeste L. Pearce, Anna H. Wu, Jolanta Kupryjanczyk, Allan Jensen, Penelope M. Webb, Kirsten B. Moysich

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Background: Comorbidities can affect survival of ovarian cancer patients by influencing treatment efficacy. However, little evidence exists on the association between individual concurrent comorbidities and prognosis in ovarian cancer patients. Methods: Among patients diagnosed with invasive ovarian carcinoma who participated in 23 studies included in the Ovarian Cancer Association Consortium, we explored associations between histories of endometriosis; asthma; depression; osteoporosis; and autoimmune, gallbladder, kidney, liver, and neurological diseases and overall and progression-free survival. Using Cox proportional hazards regression models adjusted for age at diagnosis, stage of disease, histology, and study site, we estimated pooled HRs and 95% confidence intervals to assess associations between each comorbidity and ovarian cancer outcomes. Results: None of the comorbidities were associated with ovarian cancer outcome in the overall sample nor in strata defined by histologic subtype, weight status, age at diagnosis, or stage of disease (local/regional vs. advanced). Conclusions: Histories of endometriosis; asthma; depression; osteoporosis; and autoimmune, gallbladder, kidney, liver, or neurologic diseases were not associated with ovarian cancer overall or progression-free survival. Impact: These previously diagnosed chronic diseases do not appear to affect ovarian cancer prognosis.

Original languageEnglish (US)
Pages (from-to)1470-1473
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume26
Issue number9
DOIs
StatePublished - Sep 1 2017

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'History of comorbidities and survival of ovarian cancer patients, results from the ovarian cancer association consortium'. Together they form a unique fingerprint.

Cite this